Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translati...

Related Keywords

Colorado Convention Center ,Colorado ,United States ,Boston ,Massachusetts ,Denver ,American ,Marcio Souza ,American Academy Of Neurology ,Praxis Precision Medicines Inc ,Linkedin ,Exchange Commission ,Facebook ,Program To Evaluate The Efficacy ,Tremor Program ,Nasdaq ,Precision Medicines ,American Academy ,Colorado Convention ,Clinical Trial Design ,Exhibit Hall ,Neurologic Care Industry Presentation ,Decentralized Phase ,Praxi Phase ,Ulixacaltamide Treatment ,Essential Tremor ,Concomitant Propranolol ,Four Seasons ,Praxi Cerebrum ,Private Securities Litigation Reform Act ,Annual Report ,Although Praxi ,